GCTS
GCT Semiconductor Holding, Inc.
GCTS trails on the overall score without a compensating advantage in the available component scores.
SNDK
Sandisk Corporation
SNDK has the edge over GCTS overall, supported by stronger fundamentals and stronger modeled upside.
GCTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
GCTS's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
GCTS PE Valuation
GCTS has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
GCTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect GCTS's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
GCTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.64 | +$0.17 |
| Q2 2026 | -$0.81 | -$0.09 |
| Q1 2026 | -$0.82 | -$0.34 |
| Q4 2025 | -$0.82 | -$0.52 |
GCTS lost $0.64 per share over the past year, a smaller loss than the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over GCTS in the latest year-over-year earnings comparison.
GCTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1M | +149% |
| Q2 2026 | $971K | -18% |
| Q1 2026 | $1.9M | +287% |
| Q4 2025 | $758K | -58% |
| Q3 2025 | $430K | -84% |
| Q2 2025 | $1.2M | -19% |
| Q1 2025 | $496K | -85% |
GCTS's revenue is recovering but still below its 2024 peak: $1M last quarter, up 149% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -690% | +1463 points |
| Q2 2026 | -764% | -121 points |
| Q1 2026 | -319% | +1241 points |
| Q4 2025 | -1577% | -1164 points |
| Q3 2025 | -2152% | -1926 points |
| Q2 2025 | -642% | -160 points |
| Q1 2025 | -1560% | -1782 points |
| Q4 2024 | -413% | N/A |
GCTS's operating margin was −690% last quarter, up 1462 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over GCTS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over GCTS on profitability, with a higher operating margin.
GCTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.3M | -$2.5M |
| Q2 2026 | -$16.9M | -$8.1M |
| Q1 2026 | -$7.5M | +$575K |
| Q4 2025 | -$8.5M | -$5.9M |
| Q3 2025 | -$7.8M | -$3.1M |
GCTS has burned cash in almost every quarter: −$43M over the past year, against −$27M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over GCTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GCTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +9.3M shares |
| 1 year | +78% | +40.2M shares |
GCTS has 92M diluted shares, up 78% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over GCTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
GCTS Net Leverage
GCTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
GCTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.6 | Neutral |
| Stochastic | 15.3 | Oversold |
GCTS's weekly RSI is 46 (neutral) and its Stochastic is 15 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
GCTS PE vs Technology Sector
GCTS has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
GCTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 6.7% below |
| 20 week MA | $1.92 | 20% below |
| 50 week MA | $1.73 | 11% below |
| 100 week MA | $1.68 | 8.3% below |
| 200 week MA | $4.98 | 69% below |
SNDK has stronger trend alignment. GCTS is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
GCTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $9.90 | $10.2 | +2.8% |
| 2023 | $10.2 | $10.6 | +3.7% |
| 2024 | $10.6 | $2.35 | -78% |
| 2025 | $2.35 | $1.22 | -48% |
| 2026 YTD | $1.22 | $1.54 | +26% |
GCTS has finished lower in two of the last four years. It's up 26% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over GCTS on returns for 2026, with the stronger performance.